IDEXX brings clarity to the complex world of veterinary medicine through innovative diagnostic and software solutions. Key highlights from the report include the following: Significantly advanced our ...
IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical ...
Today, Zacks Equity Research discusses Veracyte VCYT, IDEXX Laboratories IDXX and Intuitive Surgical ISRG. Industry: Medical ...
Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.
Hosted on MSN
Idexx raises 2025 revenue outlook to $4.28B as inVue Dx placements surge and innovation momentum builds
Jonathan J. Mazelsky, CEO, highlighted, "IDEXX delivered a very strong quarter of performance as reflected in solid execution across all key drivers of our strategy." He emphasized rapid adoption of ...
Idexx Laboratories benefits from operating in the resilient pet healthcare industry. The company's razor-and-blade business model adds a degree of stability for investors. Idexx is soon to expand into ...
IDEXX Laboratories continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21%, ...
Pet healthcare is a large and growing global market. Veterinarians are rapidly adopting in-office diagnostic testing tools. Increased testing is the foundation of Idexx's attractive recurring-revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results